✦ LIBER ✦

Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer

✍ Scribed by R. Silvestrini; Aurora Costa; Cosimo Lequaglie; Claudia Mochen; Silvia Veneroni; Monica Leutner; Gianni Ravasi

Publisher: Springer
Year: 1998
Tongue: English
Weight: 93 KB
Volume: 432
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s004280050188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting BCL-2 family proteins to overc

Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer

✍ Emmanuelle Wesarg; Sandra Hoffarth; Rainer Wiewrodt; Monika Kröll; Stefan Bieste 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 422 KB

## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced non‐small cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and long‐term survival is rarely observed. Clinically applied anticancer drugs exert at least some of the

Immunohistochemical demonstration of apo

Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers

✍ T. Hanaoka; J. Nakayama; M. Haniuda; T.-A. Sato 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 163 KB

Potential role of bcl-2 as a suppressor

Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

✍ Michael I. Koukourakis; Alexandra Giatromanolaki; Kenneth J. O'Byrne; Ruth M. Wh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB 👁 2 views

It has been reported that genes regulating apoptosis may play a role in tumoral angiogenesis. This study examined the relationship between tumour vascularization, a measure of tumour angiogenesis, and bcl-2 and p53 expression in operable non-small-cell lung cancer (NSCLC). The relationship between b

Association of smoking with apoptosis-re

Association of smoking with apoptosis-regulated proteins (Bcl-2, Bax and p53) in resected non-small-cell lung cancers

✍ Takaomi Hanaoka; Jun Nakayama; Jun Mukai; Shinji Irie; Takeshi Yamanda; Taka-Aki 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 42 KB 👁 2 views

FIGURE 1 -Survival after surgery of patients with NSCLC according to p53 expression level. Log-rank tests used for comparisons.

Resting energy expenditure in patients w

Resting energy expenditure in patients with non-small cell lung cancer

✍ E. W. H. M. Fredrix; E. F. M. Wouters; P. B. Soeters; A. C. J. M. Van Der Aalst; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Mitochondrial DNA mutation correlates wi

Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer

✍ Wataru Matsuyama; Masanori Nakagawa; Joeji Wakimoto; Yasunobu Hirotsu; Masaharu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

The optimal management of patients with nonsmall cell lung cancer (NSCLC) depends on the accuracy of appropriate staging strategies. The best approach for clinical staging, especially the evaluation of lymph node metastasis, continues to confound clinicians. A specific, less-invasive method to suppo